News GeneLink, Inc.

Equities

Delayed OTC Markets Other stock markets 02:48:16 2024-01-29 pm EST			5-day change	1st Jan Change
0.000001 ^USD	-.--%		-.--%	-.--%

2015	GeneLink Inc. Emerged from Bankruptcy	CI
2015	Second Amended Reorganization Plan and Disclosure Statement Approved for GeneLink Inc.	CI

GeneLink Inc. Emerged from Bankruptcy	15-06-10	CI
Second Amended Reorganization Plan and Disclosure Statement Approved for GeneLink Inc.	15-01-16	CI
Second Amended Reorganization Plan and Disclosure Statement Filed by GeneLink Inc.	14-10-29	CI
First Motion for Exclusivity Period Extension Approved For GeneLink Inc.	14-10-29	CI
First Amended Disclosure Statement Conditionally Approved for GeneLink Inc.	14-10-23	CI
First Amended Reorganization Plan and Disclosure Statement Filed by GeneLink Inc.	14-10-21	CI
First Motion for Exclusivity Period Extension Filed by GeneLink Inc.	14-10-14	CI
Reorganization Plan and Disclosure Statement Filed by GeneLink Inc.	14-06-13	CI
Amended DIP Financing Approved for GeneLink Inc.	14-05-28	CI
GeneLink Inc. will Change its Ticker to GNLK.Q from GNLK	14-04-30	CI
Interim DIP Financing Approved for GeneLink Inc.	14-04-28	CI
GeneLink Inc. Filed for Bankruptcy	14-04-18	CI
GeneLink, Inc. Appoints Michael G. Smith as Chief Operating Officer and Interim Chief Financial Officer	13-11-14	CI
GeneLink Inc. Announces Resignation of Two Directors	13-07-08	CI
Genelink Inc. Announces Board Changes	13-06-12	CI
GeneLink Inc. Announces Earnings Results for the Fiscal Year Ended December 31, 2012	13-04-04	CI
GeneLink Inc. announced that it expects to receive $0.60 million in funding.	13-04-04	CI
GeneLink Inc. Announces Executive Changes	13-02-12	CI
GeneLink Inc. Announces Executive Changes, Effective from July 13, 2012	12-07-17	CI
GeneLink Inc. announced that it expects to receive $1.50 million in funding.	12-06-20	CI

No results for this search